Hepatology Articles & Analysis: Older
12 news found
Following with the announcement of developing small molecule drug for glaucoma, Ace Therapeutics recently unveiled disease model customization services to accelerate further the preclinical research on gastroenterology (GI) and hepatology. Gastrointestinal (GI) and liver diseases are complex conditions that can greatly impact a person's quality of life. ...
Recent evidence suggests that β-catenin plays an important role in various aspects of hepatology, including liver development (embryonic and postnatal), liver regeneration after partial hepatectomy, HGF-induced hepatomegaly, liver partitioning, and liver cancer pathogenesis. ...
CDx Diagnostics, Inc. announced that the WATS3D view, published in Clinical Gastroenterology and Hepatology. WATS3D uses a unique wide-area sampling instrument, proprietary 3D imaging with AI analysis, and expert pathologists to reliably identify abnormal cells to help physicians prevent esophageal cancer. ...
Details for the oral presentation are as follows: Title: Pemvidutide (ALT-801), a novel GLP-1/Glucagon Dual Receptor Agonist, Achieves Rapid and Potent Reductions in Body Weight and Liver Fat: Results of a Placebo-Controlled, Double-Blind, First-in-Human (FIH) Clinical Trial Presenter: Stephen Harrison, M.D., Visiting Professor of Hepatology, Radcliffe Department of Medicine, ...
Kenneth Wang, Director of Esophageal Neoplasia Clinic and Consultant in the Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, USA. ...
LiverTox: a website on drug‐induced liver injury. Hepatology. 2013. ...
About Digestive Disease Week Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA) Institute, the ...
Global epidemiology of nonalcoholic fatty liver disease – Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, ...
Chan, head of the Division of Gastroenterology and Hepatology, Director of the Institute of Digestive Disease, the Center for Liver Health, and the Office of Global Engagement. ...
“Measuring patients with fatty liver disease and high BMI is challenging because the increased thickness of subcutaneous adipose tissue in these patients may affect diagnostic accuracy,” explains presenting author Dr. Michael Curry, Director of Hepatology at Beth Israel Deaconess Medical Center. “Previous studies have shown that including sections of ...
Mohamed Othman, Associate Professor of Medicine (Gastroenterology & Hepatology) at Baylor College of Medicine; Dr. Emre Gorgun, Director of Endoluminal Surgery Center, Lower GI (Colorectal Surgery) at the Cleveland Clinic; and Dr. Joo Ha Hwang, Professor of Medicine (Gastroenterology & Hepatology), Stanford University Medical Center — will discuss ...
This is according to an observational study published in The Lancet Gastroenterology & Hepatology journal, which looked at long-term data for colon and rectal cancer incidence in 21 population-based registries across Australia (1983-2012), Canada (1995-2014), Denmark (1978-2012), Ireland (1995-2013), New Zealand (1995-2014), Norway (1953-2014), and the UK (1995-2014). ...